Effects of bazedoxifene/conjugated estrogens on reproductive endocrinology and reproductive tract ultrasonographic appearance in premenopausal women: a preliminary study. (4th May 2019)
- Record Type:
- Journal Article
- Title:
- Effects of bazedoxifene/conjugated estrogens on reproductive endocrinology and reproductive tract ultrasonographic appearance in premenopausal women: a preliminary study. (4th May 2019)
- Main Title:
- Effects of bazedoxifene/conjugated estrogens on reproductive endocrinology and reproductive tract ultrasonographic appearance in premenopausal women: a preliminary study
- Authors:
- Flores, Valerie A.
Leone, Cheryl
Taylor, Hugh S.
Stachenfeld, Nina S. - Abstract:
- Abstract: Bazedoxifene (BZA) paired with conjugated estrogens (CE) is the first tissue selective estrogen receptor complex (TSEC) approved by the United States Food and Drug Administration for the treatment of menopausal symptoms. Clinical trials in menopausal women and in premenopausal murine models of endometriosis have demonstrated safety and efficacy, however, the impact of BZA/CE on premenopausal women is not known. Here we report a case series study in premenopausal women assessing effects of BZA/CE on reproductive hormones, and uterine/ovarian ultrasonographic appearance. After one monitoring cycle, five subjects underwent daily administration of BZA/CE (20 mg/0.45 mg) for 12 weeks, and were followed for 4 weeks after treatment. Uterine/ovarian morphology was assessed with ultrasound, and endocrinologic function with ovulation prediction kits and serum assessment of reproductive hormones throughout the menstrual cycle. All subjects demonstrated an LH surge on the medication; interestingly there was a significant decrease in luteinizing hormone level during treatment compared to posttreatment values. BZA/CE was well-tolerated in premenopausal women and did not induce clinically relevant reproductive hormone changes, endometrial alterations, or abnormal ovarian folliculogenesis.
- Is Part Of:
- Gynecological endocrinology. Volume 35:Number 5(2019)
- Journal:
- Gynecological endocrinology
- Issue:
- Volume 35:Number 5(2019)
- Issue Display:
- Volume 35, Issue 5 (2019)
- Year:
- 2019
- Volume:
- 35
- Issue:
- 5
- Issue Sort Value:
- 2019-0035-0005-0000
- Page Start:
- 390
- Page End:
- 394
- Publication Date:
- 2019-05-04
- Subjects:
- Bazedoxifene -- conjugated estrogens -- premenopausal -- reproductive tract -- selective estrogen receptor modulators
Endocrine gynecology -- Periodicals
Generative organs, Female -- Diseases -- Periodicals
618.1 - Journal URLs:
- http://informahealthcare.com/journal/gye ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/09513590.2018.1559288 ↗
- Languages:
- English
- ISSNs:
- 0951-3590
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4233.720000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 14161.xml